Oragenics Inc. (OGEN)
0.17
-0.01 (-4.82%)
At close: Apr 17, 2025, 3:58 PM
0.18
0.61%
After-hours: Apr 17, 2025, 08:00 PM EDT
-4.82% (1D)
| Bid | 0.17 |
| Market Cap | 3.76M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.57M |
| EPS (ttm) | -1.6 |
| PE Ratio (ttm) | -0.11 |
| Forward PE | -0.49 |
| Analyst | n/a |
| Ask | 0.18 |
| Volume | 211,258 |
| Avg. Volume (20D) | 4,879,296 |
| Open | 0.18 |
| Previous Close | 0.18 |
| Day's Range | 0.17 - 0.18 |
| 52-Week Range | 0.16 - 3.43 |
| Beta | 0.87 |
About OGEN
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 25, 2004
Employees 3
Stock Exchange AMEX
Ticker Symbol OGEN
Website https://www.oragenics.com
6 months ago
+6.39%
Oragenics shares are trading higher after the comp...
Unlock content with
Pro Subscription
7 months ago
-46.2%
Oragenics shares are trading lower after the company announced $4.45 million public offering of 8,106,584 shares at $0.55 per share.
